On 4 February 2026, Biosino Bio-Technology and Science Incorporation’s indirect non-wholly owned subsidiary, Biosino Hefei Medical Technology Co., Ltd., was awarded “2025 Innovative Technology Rising Star Enterprise of Hefei Economic & Technological Development Area.” The recognition was conferred by the Party Working Committee and Management Committee of Hefei Economic & Technological Development Area in acknowledgement of its innovation capabilities and development potential in in vitro diagnostics.

Biosino Hefei Medical Technology Co., Ltd. has made notable progress with its 4-laser 21-color BioCyteX (Clinical) High-End Flow Cytometer, obtaining certification (Anhui Medical Device Registration Certificate No. 20252220150). This milestone marks the first domestically produced high-end 4-laser flow cytometer in China to achieve such registration, with performance comparable to internationally imported brands. The instrument’s four semiconductor lasers work in synergy to simultaneously excite 21 fluorescent dyes, acquiring 24 key parameters at internationally leading levels of detection sensitivity, resolution, and stability.

Since its establishment in 2022, Biosino Hefei Medical Technology Co., Ltd. has leveraged the area’s innovation resources to achieve breakthroughs in R&D and market promotion. Its products now hold multiple certifications and serve 31 provinces, municipalities, and autonomous regions across China, as well as overseas markets. The newly bestowed title highlights the company’s expanding influence in technological innovation and establishes a strong foundation for future development in the healthcare sector.